Short-term Reactivation of Retinopathy of Prematurity after Primary Ranibizumab Treatment

November 2024  Monique Munro MD FRCSC University of Calgary, Section of Ophthalmology Calgary Alberta Strawbridge J, Cheng JY, Gundlach BS, Gillespie T, Karmouta R, Khitri M, Chu A, Tsui I. Short-term reactivation of retinopathy of prematurity after primary ranibizumab treatment. Retina. 2024 Nov 1;44(11):1945-1951. Current treatment options for Type 1 retinopathy of prematurity (ROP) includes […]

Oral Hypoxia-Inducible Factor 2a inhibitor Belzutifan in Ocular von Hippel-Lindau Disease

August 2024  Kapil Mishra M.D. Gavin Herbert Eye Institute University of California, Irvine   Wiley HE, Srinivasan R, Maranchie JK, et al. Oral hypoxia-inducible factor 2α inhibitor belzutifan in ocular von hippel-lindau disease. Ophthalmology. Published online June 2024:S0161642024003191. Von Hippel-Lindau (VHL) disease is a hereditary condition characterized by the development of tumors in multiple organs […]

Endophthalmitis after Anti-VEGF Intravitreal Injections with Aqueous Chlorhexidine versus Povidone-Iodine as Ocular Antiseptics

May 2024  Samir N. Patel, MD Retina Vitreous Consultants, Pittsburgh PA   Ton NS, Goncharov V, Zapata I, Adam MK. Endophthalmitis after Anti-VEGF Intravitreal Injections with Aqueous Chlorhexidine versus Povidone-Iodine as Ocular Antiseptics. Ophthalmol Retina. 2023 Dec 18:S2468-6530(23)00648-6. PMID: 38122867. Infectious endophthalmitis is a rare but potentially severe complication of intravitreal injections. Multiple strategies have […]

Risk of Endophthalmitis Based on Cumulative Number of Anti-Vascular Endothelial Growth Factor Intravitreal Injections

February 2024  Matt R. Starr, MD Vitreoretinal Surgery Mayo Clinic Rochester, MN   Rachel N. Israilevich, MD, Hana Mansour, MD, Samir N. Patel, MD, Sunir J. Garg, MD FACS, Michael A. Klufas, MD, Yoshihiro Yonekawa, MD, Carl D. Regillo, MD FACS, Jason Hsu, MD. Risk of Endophthalmitis Based on Cumulative Number of Anti-Vascular Endothelial Growth […]

Intravitreal Therapy for Uveitic Macular Edema – Ranibizumab versus Methotrexate versus the Dexamethasone Implant: The MERIT Trial Results

February 2024  Jordan D. Deaner, MD Uveitis and Vitreoretinal Surgery Mid Atlantic Retina, Wills Eye Hospital Assistant Professor, Thomas Jefferson University Philadelphia, PA   Multicenter Uveitis Steroid Treatment Trial (MUST) Research Group, Writing Committee:; Acharya NR, Vitale AT, Sugar EA, Holbrook JT, Burke AE, Thorne JE, Altaweel MM, Kempen JH, Jabs DA. Intravitreal Therapy for […]

Retinal Displacement after Scleral Buckle versus Combined Buckle and Vitrectomy for Rhegmatogenous Retinal Detachment

January 2024   Shivani V. Reddy, MD Talley Eye Institute Evansville IN   Bansal A, Naidu SC, Marafon SB, et al. Retinal Displacement after Scleral Buckle versus Combined Buckle and Vitrectomy for Rhegmatogenous Retinal Detachment: ALIGN Scleral Buckle versus Pars Plana Vitrectomy with Scleral Buckle. Ophthalmol Retina. 2023;7(9):788-793. doi:10.1016/j.oret.2023.05.012   Low integrity retinal attachment (LIRA), a […]